Publications by authors named "S Oudard"

Claim this Profile
F
Feasibility of standard versus fractionated carboplatin-paclitaxel in older adults with ovarian cancer: a retrospective study.
Elisabeth Ashton, Nicolas Delanoy, Rym El Gharib, Adrien Rochand, Claire Gervais, Stéphane Oudard

Int J Gynecol Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PARP Inhibitors in Metastatic Castration-resistant Prostate Cancer: Rationale, Mechanisms, and Clinical Applications.
Stéphane Oudard, Marc-Olivier Timsit, Denis Maillet, Guillaume Mouillet, Luca Campedel

Eur Urol Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab in Metastatic Clear-cell Renal Cell Carcinoma: An Integrative Biomarker Analysis from the NIVOREN GETUG-AFU 26 Phase 2 Study.
Ronan Flippot, Yann-Alexandre Vano, Cécile Dalban, Benoit Beuselinck, Aude Fléchon, Stéphane Oudard

Eur Urol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The CD70-CD27 Axis in Cancer Immunotherapy: Predictive Biomarker and Therapeutic Target.
Ikuan Sam, Nadine Ben Hamouda, Marina Alkatrib, Cecile Gonnin, Peter J Siska, Stephane Oudard

Clin Cancer Res· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cabozantinib plus atezolizumab in metastatic prostate cancer (CONTACT-02): final analyses from a phase 3, open-label, randomised trial.
Neeraj Agarwal, Arun A Azad, Joan Carles, Nobuaki Matsubara, Stéphane Oudard

Lancet Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis